The ethics of research involving animals - Nuffield Council on ...

T h e e t h i c s o f r e s e a r c h i n v o l v i n g a n i m a l s
Graham Moore
Consultant (Science Policy and Scientific Affairs)
Anon.
Certificate Holder
Anon.
Named Veterinary Surgeon
Anon.
Named Animal Care and Welfare Officer
Anon.
Director <strong>of</strong> Animal Welfare
Anon.
Project Licence Holder – Veterinary Medicines
Anon.
Personal Licensee – Human Medicinals
Anon.
Home Office Liaison Officer
Programme:
■ Introduction to drug discovery and development at Pfizer;
■ discussion: sourcing, husbandry and use <strong>of</strong> <strong>animals</strong> in human and veterinary <strong>research</strong>,
transferring results from <strong>animals</strong> to humans, regulatory aspects <strong>of</strong> animal <strong>research</strong>, ethical
review and decision making, engagement with the public and information programmes;
■ tour <strong>of</strong> the ‘small animal’ animal facilities and discussion with staff on current medicines <strong>research</strong>
programmes <strong>involving</strong> rodents and terminally anaesthetised rabbits (a scheduled visit to the dog
laboratories was cancelled because the facilities were not accessible on the day <strong>of</strong> the visit due
to construction work; however, members were invited to view these on another occasion);
■ tour <strong>of</strong> non-animal <strong>research</strong> area and introduction to Automated Laboratory In Vitro Assay
Systems (ALIAS).
16 September 2003, London
Meeting at 28 Bedford Square, as part <strong>of</strong> the fourth meeting <strong>of</strong> the Working Party
Rosie Barnes
Chief Executive, Cystic Fibrosis Trust
Christine Cryne
Executive Director, Muscular Dystrophy Campaign
Robert Meadowcr<strong>of</strong>t
Director <strong>of</strong> Information, Policy and Research, Parkinson’s Disease Society
Programme:
■ Introductions to the campaigning and information activities <strong>of</strong> the charities;
■ discussion about the usefulness <strong>of</strong> animal models for cystic fibrosis, muscular dystrophy and
Parkinson’s disease; decisions about funding <strong>research</strong> on <strong>animals</strong>; outreach and relation to
activist groups; concerns <strong>of</strong> members <strong>of</strong> charities about <strong>research</strong> on <strong>animals</strong> and the question
<strong>of</strong> whether or not it poses a moral dilemma.
300